Last month, the US Food and Drug Administration (FDA) announced that it would begin daily publication of adverse event data for drugs and biologics via the FDA Adverse Event Reporting System (FAERS).
The U.S. Food and Drug Administration is now providing real-time, daily publication updates on adverse event data from its reporting system. In an effort to modernize and provide transparency on ...
Last month the Food and Drug Administration (FDA or the Agency) announced the launch of the FDA Adverse Event Reporting System (FAERS) Public Dashboard for Cosmetic Products. This interactive ...
The FDA announced that adverse event data from the FAERS will now be published daily. HealthDay News — The US Food and Drug Administration is now providing real-time, daily publication updates on ...
The U.S. Food and Drug Administration said that it has begun the daily publication of adverse event reports related to drugs and biological products. This marks a shift from the previous quarterly ...
A new commission will investigate the prevalence of SSRI antidepressants as adverse event reports document hundreds of cases of homicidal ideation and homicide. A newly released analysis of FDA ...
To increase transparency, the agency is publishing data from the FDA Adverse Event Reporting System daily rather than quarterly. (HealthDay News) — The U.S. Food and Drug Administration is now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results